AMH, FSH & AFC: Understanding Your Fertility Numbers

Three numbers run the early chapters of every fertility story — AMH, FSH, and AFC — and almost everyone reads them wrong the first time, usually alone, usually at midnight, usually as a verdict. They aren't one. Reserve markers measure quantity — how many eggs remain and how a stimulation cycle is likely to go — not quality, not your odds of conceiving naturally this month, and not whether you'll ever hold a baby. Here's what each number actually is, what it predicts, what it emphatically doesn't, how the three cross-check each other, and how physicians actually use them together at a consult.

AMH — the Workhorse

Anti-Müllerian hormone is produced by the granulosa cells of small growing follicles, so blood AMH tracks the size of the recruitable pool — drawable any cycle day, reasonably stable month to month, and the single most-used reserve marker in modern practice. Rough interpretive bands (assay-dependent — always read against your lab's ranges): above ~3–4 ng/mL suggests high reserve (and PCOS territory at the top, with OHSS-risk implications for stimulation); ~1–3 ng/mL is the broad normal band; below ~1 ng/mL flags diminished reserve; below ~0.5 signals a genuinely limited pool. What AMH predicts well: egg yield under stimulation — it's the number your protocol and dosing are largely built from, as the protocols guide details. What it predicts poorly: natural conception — well-designed cohort studies found low-AMH women conceiving naturally at essentially normal rates over a year, because natural conception needs one good egg a month, not a large pool. A low AMH at 32 is a planning signal, not a diagnosis of infertility; a normal AMH at 43 is not reassurance about egg quality. Both misreadings cause real harm in opposite directions.

AFC and FSH — the Cross-Checks

Antral follicle count is the ultrasound version of the same question: a transvaginal scan early in the cycle counts the small (2–10mm) follicles visible on both ovaries. Bands run roughly: 15+ high (PCOS-range at the top), 8–15 typical, under ~5–7 diminished. AFC and AMH usually agree — they measure the same pool by different windows — and when they diverge, the discordance itself is diagnostic information worth a conversation rather than a coin flip. FSH, the veteran marker, is drawn on cycle day 2–4 and read with estradiol: the brain secretes more FSH to push reluctant ovaries, so elevated day-3 FSH (roughly >10–12 IU/L, lab-dependent) signals the system working harder — but a high estradiol level can suppress FSH into deceptive normalcy, which is why the pair travels together and single-number FSH reassurance is an amateur read. FSH also bounces cycle to cycle more than AMH, one reason it ceded the workhorse role. None of the three, it bears repeating, measures egg quality — the chromosomal competence that drives fertilization, blastocyst development, and miscarriage risk — because quality has no blood test: age remains its best proxy, embryology outcomes its only direct readout.

How the Numbers Are Actually Used

In a fertility workup the trio does three jobs. Protocol and dose selection: high reserve steers toward antagonist protocols with OHSS-safe triggers; diminished reserve steers dosing conversations and sometimes mild-protocol strategies — the matching logic of the protocols comparison. Expectation-setting for yield: reserve markers forecast how many eggs a cycle retrieves, which cascades through the attrition funnel the pillar guide draws — fewer eggs means fewer blastocysts means the cumulative-cycle math starts earlier. Urgency calibration: a genuinely low AMH in a patient wanting children later is the classic fertility-preservation conversation-starter — not because the number dooms natural conception now, but because it forecasts what a banking cycle can harvest and how that forecast degrades with waiting. What the numbers are not used for by good clinicians: turning patients away with a single value, promising outcomes from a single value, or substituting for the fuller workup — semen analysis (half of infertility involves male factor), tubal and uterine evaluation — that actually locates the problem. A cheap first look at the whole picture is also one of medical travel's quiet use cases, via our live guide on fertility testing abroad.

The Numbers in Motion — Retesting and Trend Lines

One reading habit separates planners from panickers: reserve markers are trend data, not snapshots. AMH assays vary between labs and platforms enough that a single surprising value deserves a repeat (same lab, if possible) before it deserves a decision; AFC varies with the sonographer and the cycle; FSH famously bounces month to month. What clinicians actually watch is trajectory — a 1.2 that was 2.1 two years ago tells a different story than a stable 1.2 — and the practical corollary for anyone deferring family plans is simple: get a baseline now, whatever the number, because the value of every future test doubles when there's something to compare it against. Retesting annually is reasonable for watchers; retesting monthly is anxiety with a lab bill.

And two numbers that share the workup deserve honorary membership in the trio: estradiol, whose day-3 value validates the FSH read as described above, and TSH — thyroid function — whose optimization is one of the workup's few genuinely cheap, evidence-supported wins before any cycle starts.

The Bottom Line

AMH forecasts stimulation yield; AFC cross-checks it visually; FSH-with-estradiol adds the veteran's second opinion — and all three together still measure only quantity, while age quietly governs the quality that decides outcomes. Read your numbers against your lab's ranges, with a physician, in the context of the full workup; treat a scary value as a planning input rather than a sentence; treat a comfortable value as one green light rather than a guarantee; and remember the pattern this whole site keeps finding: the number that matters most is rarely the one on the report — it's the cumulative, whole-journey arithmetic those reports feed into.